MedReleaf Australia is a Queensland-based company established in 2016. We provide a Prescriber Program to Doctors, with a focus on the endocannabinoid system (ECS), following the patient qualifying guidelines of the Therapeutic Goods Association (TGA)

MedReleaf Australia partnered with MedReleaf Corp, Aurora Cannabis’ wholly owned subsidiary. MedReleaf Australia is federally licensed to cultivate and manufacture medical cannabis by the Federal Government’s Office of Drug Control (ODC), backed by more than 40 years of pharmaceutical and healthcare expertise, driven by Research and Development.

We dedicate ourselves to innovation and operational excellence. MedReleaf Australia is planning the construction of its state-of-art Australian facility in Queensland. Until then, a range of MedReleaf, Aurora and CanniMed products have been imported to the Australian medical market.

This is the widest range of medical cannabis products in Australia and has been carefully cultivated in one of several state-of-the-art ICH-GMP, ISO 9001 certified facilities in Canada, owned by our largest shareholder, Aurora Cannabis Inc.